MACKENZIE HOUSER: Open Payments
NPI 1336510163 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,681 in 176 payments from 34 companies in 2025. Trend: 2023 $246 · 2024 $2,104 · 2025 $4,681
Food & beverage: $3,964Long term medical supply or device loan: $598Education: $119
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $925 |
| AstraZeneca Pharmaceuticals LP | 22 | $691 |
| Janssen Biotech, Inc. | 11 | $292 |
| Daiichi Sankyo Inc. | 13 | $279 |
| Merck Sharp & Dohme LLC | 13 | $278 |
| Incyte Corporation | 14 | $259 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $177 |
| ABBVIE INC. | 8 | $162 |
| Celgene Corporation | 6 | $153 |
| Gilead Sciences, Inc. | 7 | $141 |
Products named: KISQALI, Enhertu, KEYTRUDA, Nubeqa, ERLEADA, REBLOZYL, CALQUENCE, Trodelvy.
Industry payments across PA — which companies pay providers there.
